Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension

Published:2022-04-28 Issue:11 Volume:21 Page:1423-1432
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Chang Sung-A¹,Lee Sang Hyun²,Choi Jung Hyun³,Chung Wook-Jin⁴,Choi Jae Young⁵,Kim Hyung-Kwan⁶,Jung Hae-Ok⁷,Park Seong-Mi⁸,Kim Won-Jang⁹,Jung Su Young¹⁰,Chang Hyuk-Jae¹¹^ORCID

Affiliation:

1. Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

2. Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan, Republic of Korea

3. Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Pusan, Republic of Korea

4. Division of Cardiology, Department of Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea

5. Division of Pediatric Cardiology, Congenital Heart Disease Center, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

6. Division of Cardiology, Department of Internal Medicine Seoul National University College of Medicine, Section of Cardiovascular Imaging, Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea

7. Division of Cardiology, Department of Medicine, The Catholic University of Korea Seoul St. Mary’s Hospital, Seoul, Republic of Korea

8. Division of Cardiology, Korea University Medicine, Anam hospital, Seoul, Republic of Korea

9. Division of Cardiology, Department of Cardiology, CHA Bundang Medical Center, CHA University School of Medicine, Republic of Korea

10. Medical Affairs, Janssen Korea Ltd, Seoul, Republic of Korea

11. Division of Cardiology, Severance Cardiovascular Hospital, Yonsei College of Medicine, Seoul, Republic of Korea

Funder

project grant from Janssen Korea Ltd

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2069750

Reference22 articles.

1. Death in Pulmonary Arterial Hypertension

2. Demographics, treatment trends, and survival rate in incident pulmonary artery hypertension in Korea: A nationwide study based on the health insurance review and assessment service database

3. Evaluation and management of pulmonary arterial hypertension

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review;ClinicoEconomics and Outcomes Research;2024-05

2. A Descriptive Study of a Clinical Pharmacist’s Role in the Outpatient Pulmonary Hypertension Clinic in the United States (CliPR-PH);2023-06-25

3. Impact of mask use on face recognition: an eye-tracking study;Cognitive Research: Principles and Implications;2022-04-08